Literature DB >> 6445798

Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia.

P Hersey, J Wotherspoon, G Reid, F W Gunz.   

Abstract

The underlying basis for hypogammaglobulinaemia in patients with chronic lymphatic leukaemia (CLL) was investigated by measurement if immunoglobulin produced in vitro in cultures of pokeweek mitogen-stimulated B and T lymphocytes. B and T cells were separated by sheep red blood cell rosette techniques and, by culture of these cells from CLL patients in various combinations with B or T cells from normal subjects, it was possible to measure independently the function of B lymphocytes and the helper or suppressor function of T lymphocytes. By these methods it was found that the B lymphocytes of six of eight patients failed to produce immunoglobulins in vitro. B lymphocytes from two patients appeared to produce immunoglobulins in vitro. T lymphocytes from five of the eight patients had low or undetectable helper T cell function and in six patients their T lymphocytes had excessive suppressor activity in comparison to T lymphocyte populations from normal subjects. Whether the primary abnormality in the CLL T cell populations was a deficiency of helper T cells or excess of suppressor T cells was uncertain from these studies. These results suggest that immunoglobulin production by B lymphocytes from most patients with CLL was abnormal but also that T cells from CLL patients may be abnormal in respect to their role in immunoglobulin production at an early stage of the disease. These findings may assist in understanding the pathogenesis of this disease and lead to new approaches in treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445798      PMCID: PMC1538113     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Characterization of mononuclear effector cells in human blood.

Authors:  P Hersey; A Edwards; J Edwards
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 degrees C.

Authors:  K Kumagai; T Abo; T Sekizawa; M Sasaki
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

3.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

4.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

5.  Isolation of normal T cells in chronic lymphatic leukaemia.

Authors:  J Wybran; S Chantler; H H Fudenberg
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Quantitative studies on the response of normal and leukaemic lymphocytes to phytohaemagglutinin.

Authors:  J M Shaw; E E Hagon; P C Vincent; F W Gunz
Journal:  Aust J Exp Biol Med Sci       Date:  1974-02

8.  Use of laser nephelometry in the measurement of serum proteins.

Authors:  C D Deaton; K W Maxwell; R S Smith; R L Creveling
Journal:  Clin Chem       Date:  1976-09       Impact factor: 8.327

9.  Metabolism of radio-iodinated IgG in patients with abnormal IgG levels. I. Hypergamma-globulinaemia.

Authors:  J V Wells; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

10.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

View more
  12 in total

1.  Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release.

Authors:  P Hersey; A Edwards; R Lewis; A Kemp; J McInnes
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

2.  Reduced T lymphocyte colonies in B chronic lymphocytic leukaemia. III. Evidence of a proliferative abnormality of the T helper cell population.

Authors:  R Foa; F Lauria
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

3.  Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.

Authors:  F Herrmann; G Sieber; Z Chen; B Enders; B Komischke; H Rühl
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

4.  Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.

Authors:  P Hersey; K Ho; J Werkmeister; U Abele
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

5.  Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes.

Authors:  A P Johnstone; J C Jensenius; R E Millard; L Hudson
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

6.  Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro.

Authors:  J Werkmeister; R Zbroja; W McCarthy; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

Review 7.  A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia.

Authors:  S Lachance; A L Christofides; J K Lee; L H Sehn; B C Ritchie; C Shustik; D A Stewart; C L Toze; E Haddad; D C Vinh
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 8.  Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?

Authors:  Fatima Dhalla; Mary Lucas; Anna Schuh; Malini Bhole; Rashmi Jain; Smita Y Patel; Siraj Misbah; Helen Chapel
Journal:  J Clin Immunol       Date:  2014-02-21       Impact factor: 8.317

9.  In vitro immune cell function in six cases of immunoproliferative small intestinal disease after long term remission.

Authors:  M López-Botet; C Chantar; A Plaza; L Abreu; M Kreisler; M O de Landázuri
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

Review 10.  Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.

Authors:  Silvia Sánchez-Ramón; Fatima Dhalla; Helen Chapel
Journal:  Front Immunol       Date:  2016-08-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.